Cypris vs. CAS SciFinder
SciFinder is built to search the chemistry record. Cypris is built to support R&D decisions across the full innovation landscape. Connect compounds, patents, scientific literature, competitors, markets, and regulatory intelligence in one answer, not across disconnected tools.

Powering world-leading R&D & IP teams
Two tools. Two very different jobs.
SciFinder is a purpose-built chemistry index with deep CAS content and strong substance search. The Cypris Chemical Intelligence Layer connects chemical, scientific, patent, commercial, and regulatory intelligence in one place, so a single prompt returns an answer your team can act on without switching tools or constructing complex queries.
Cypris connects chemical data with 180M patents, 270M+ papers, 10M+ company profiles, and market and regulatory intelligence. A single compound question can return the surrounding IP, scientific, competitive, and commercial context, with additional coverage from PubChem and other authoritative databases.
SciFinder often requires researchers to assemble synonyms, trade names, and registry identifiers before searching. Cypris automatically resolves hundreds of synonyms, CAS numbers, trade names, and supplier designations before the search begins.
SciFinder provides limited commercial and regulatory context, often requiring teams to search elsewhere. Cypris brings TSCA, REACH, EPA status, suppliers, commercial signals, patents, and scientific literature into one answer, making formulation risk and compliance exposure easier to assess.
SciFinder’s AI capabilities operate within the SciFinder environment. Cypris Q continuously integrates leading models from OpenAI, Anthropic, and Google, then grounds them in a chemistry-specific ontology that activates automatically when a chemical question is detected.
Where it matters most for chemistry-driven R&D
One prompt.
The whole landscape.
Cypris Chemicals activates automatically when Q detects a chemistry-related question, then reasons across compounds, patents, literature, regulatory data, and commercial intelligence to return one connected answer.
Q detects chemical context and activates the chemistry intelligence layer automatically. Draw a structure directly in the prompt when a name is not enough.
Cypris resolves the compound across CAS numbers, synonyms, trade names, supplier identifiers, and related variants before the search begins.
The compound is matched across patents and scientific literature, surfacing relevant prior art, research, and technical evidence together.
Cypris searches TSCA, REACH, EPA, and other regulatory sources to bring compliance status into the same analysis.
Technical, competitive, regulatory, and commercial intelligence come together in one answer your team can act on.
One question.
Two very different outputs.
Prompt: “Map the landscape of tert-butyl hydroperoxide, including the active players, regulatory details, and which companies are currently using it in their products.”
200
+
36
K+
100
+
200
+
What purpose-built R&D intelligenceactually unlocks.
Derisk new formulations
Evaluate a candidate compound before it enters a product, with scientific evidence and regulatory exposure surfaced up front, not after the formulation is locked.
Run competitive intelligence
See how compounds appear across competitor patents and publications. Map the chemistry, the active players, and where the market is moving in one query.
Find connected literature & prior art
Move from a structure or compound name to the relevant patents, papers, and prior art in one pass, without constructing complex queries or assembling synonym lists.
Check regulatory status
Bring TSCA, REACH, and EPA status into the same view as the technical and commercial landscape, so compliance is evaluated earlier in the R&D process.
The Cypris Innovation Database
500M+ documents globally sourced and updated daily."The Bloomberg Terminal for innovation data." — R&D World Magazine


trade name, vendor resolution and
structure drawing search


from 150+ countries


tracked alongside the record


from 20K+ journals
The impact of movingchemical research into Cypris.
65
%+
500
M+
$
500
K+

